Cerebral Palsy Hip Outcomes Project - International Multi-centre Study

NCT ID: NCT01987882

Last Updated: 2021-02-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-06-30

Study Completion Date

2022-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary purpose of the project is to evaluate the effectiveness of different intervention strategies to prevent or relieve symptoms associated with hip instability in children with severe cerebral palsy, using the validated Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD©) questionnaire as the primary outcome measure of health-related quality of life for this population.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background: Children with severe cerebral palsy (CP) are at high risk for dislocating their hips. These hips are associated with contractures and pain, which can interfere with care-giving, seating, positioning, mobility and quality of life. The primary purpose of this project (Aim 2) is to evaluate the effectiveness of different intervention strategies to prevent or relieve the symptoms associated with hip instability in children with severe non-ambulatory CP, using the validated Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD©) questionnaire as the primary outcome measure of health related quality of life (HRQL) for this population. Secondarily, this project will also measure the impact of hip displacement on HRQL of these children. This project will be the first of its kind and this scale, which will systematically study the impact of hip instability and its management in children with severe CP, using a meaningful outcome measure that was developed specifically for this purpose. The international network of investigators/sites and the infrastructure established for this project will facilitate the long term follow-up of the participants in this study, as well as the conduct of other multi-centre clinical trials and cohort studies to evaluate the effectiveness of current and future interventions aimed at improving the quality of life of children with severe disabilities.

Study Design \& Participants: International multi-centre prospective longitudinal cohort study of children with severe (non-ambulant) cerebral palsy (GMFCS levels IV \& V) from ages 3 to 18 who have radiographic evidence of hip displacement \[Reimer's Migration Percentage (MP) ≥ 30%\].

Measures: Detailed demographic information, and prognostic factors, including co-morbid conditions will be recorded at baseline, in addition to self-administered parental reports of HRQL as measured by the CPCHILD. Hip status will be classified using standardized radiographic measures of Reimer's MP and acetabular index (AI). The primary outcome measure CPCHILD, as well as the MP \& AI will be measured at 6, 12 and 24 months following initial intervention.

Aim 1: Measure the impact of increasing hip displacement in children with severe (non-ambulant) CP on their HRQL as measured by the CPCHILD questionnaire.

Aim 2: (Primary Purpose): Measure the effectiveness of different strategies of interventions for hip displacement in children with severe (non-ambulant) CP in a prospective longitudinal comparative cohort study using the CPCHILD as the primary outcome measure of HRQL.

Aim 3: Compare the types and rates of adverse events and complications associated with each of the treatment cohorts.

Methods: Observational study of usual (site/surgeon specific) clinical practice. Investigators at each site will enroll eligible participants and assign each to one of the following 5 cohorts based on individual treating doctor's \&/or parental preferences:

A. "Natural" history or watchful waiting (N=100)

B. Serial botulinum toxin injections +/- abduction bracing (N=100)

C. Adductor (+/- psoas) muscle releases alone (N=100)

D. Hip reconstructive surgery (N=100)

E. Salvage hip surgery (N=100)

The baseline MP and CPCHILD scores for all participants will be analyzed cross-sectionally to evaluate the correlation between hip displacement and the CPCHILD scores to serve Aim 1. For Aim 2, children undergoing interventions for hip instability (Groups B, C, D, \& E) will be compared with each other as well as with their respective matched counterparts of untreated children (Group A), using repeated measures of analysis of covariance (ANOCOVA) to measure the mean change in scores from baseline at 6, 12 and 24 months after intervention.

Timelines: 500 participants will be recruited in 24 months, and followed for 24 months. The analysis, reporting of results, manuscript development and knowledge transfer will take 12 months. In total, the study will take 5 years to complete.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A. "Natural" History or Watchful Waiting

No interventions assigned to this group

B. Serial Botulinum Toxin Injections +/- Abduction Bracing

No interventions assigned to this group

C. Adductor (+/- psoas) Muscle Releases Alone

No interventions assigned to this group

D. Hip Reconstructive Surgery

No interventions assigned to this group

E. Salvage Hip Surgery

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children with a working diagnosis of cerebral palsy or cerebral palsy-like condition
* Between 2 to 18 years of age
* Has a migration percentage ≥ 30%
* Non-ambulatory; the primary mode of mobility is a wheelchair
* Parent/primary caregiver must understand one of the languages in which the CPCHILD has been translated, culturally adapted and validated.

Exclusion Criteria

* History of prior hip surgery
* Received botulinum toxin injection within the previous 3 months. Recruitment will be delayed until at least 3 months after prior botulinum toxin injection.
Minimum Eligible Age

2 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Hospital for Sick Children

OTHER

Sponsor Role collaborator

Holland Bloorview Kids Rehabilitation Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dr. Unni Narayanan, MBBS, MSc, FRCSC

Role: PRINCIPAL_INVESTIGATOR

Holland Bloorview Kids Rehab and The Hospital for Sick Children, Toronto, Canada

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shriners Hospitals for Children - Northern California

Sacramento, California, United States

Site Status RECRUITING

Children's Hospital Colorado

Aurora, Colorado, United States

Site Status RECRUITING

Alfred I. Dupont Institute

Wilmington, Delaware, United States

Site Status RECRUITING

Children's Hospital Boston

Boston, Massachusetts, United States

Site Status RECRUITING

Gillette Children's Specialty Healthcare

Saint Paul, Minnesota, United States

Site Status RECRUITING

Children's of Mississippi

Jackson, Mississippi, United States

Site Status RECRUITING

Hospital for Special Surgery

New York, New York, United States

Site Status RECRUITING

New York-Presbyterian Morgan Stanley Children's Hospital

New York, New York, United States

Site Status RECRUITING

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States

Site Status RECRUITING

Royal Children's Hospital

Melbourne, Victoria, Australia

Site Status RECRUITING

BC Children's Hospital

Vancouver, British Columbia, Canada

Site Status RECRUITING

Holland Bloorview Kids Rehabilitation Hospital

Toronto, Ontario, Canada

Site Status RECRUITING

The Hospital for Sick Children

Toronto, Ontario, Canada

Site Status RECRUITING

Shriners Hospital for Children - Canada

Montreal, Quebec, Canada

Site Status RECRUITING

Aarhus University Hospital

Aarhus, , Denmark

Site Status RECRUITING

Safra Hospital for Children

Tel Litwinsky, Ramat Gan, Israel

Site Status RECRUITING

Starship Children's Hospital of New Zealand

Auckland, , New Zealand

Site Status RECRUITING

K. Marcinkowski Medical University

Poznan, , Poland

Site Status RECRUITING

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, South Korea

Site Status RECRUITING

Lund University Hospital

Lund, , Sweden

Site Status RECRUITING

Astrid Lindgren's Children's Hospital

Stockholm, , Sweden

Site Status NOT_YET_RECRUITING

University Hospitals Coventry & Warwickshire NHS Trust

Coventry, England, United Kingdom

Site Status RECRUITING

Alder Hey Children's NHS Foundation Trust

Liverpool, England, United Kingdom

Site Status RECRUITING

Royal National Orthopaedic Hospital

London, England, United Kingdom

Site Status RECRUITING

The Royal London and St. Bartholomew's Hospitals

London, England, United Kingdom

Site Status RECRUITING

Nuffield Orthopaedic Centre NHS Trust

Oxford, England, United Kingdom

Site Status RECRUITING

Royal Hospital for Sick Children

Edinburgh, Scotland, United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Canada Denmark Israel New Zealand Poland South Korea Sweden United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Dr. Unni Narayanan, MBBS, MSc, FRCSC

Role: CONTACT

Ashley Ferkul, BA

Role: CONTACT

References

Explore related publications, articles, or registry entries linked to this study.

Narayanan UG, Fehlings D, Weir S, Knights S, Kiran S, Campbell K. Initial development and validation of the Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD). Dev Med Child Neurol. 2006 Oct;48(10):804-12. doi: 10.1017/S0012162206001745.

Reference Type BACKGROUND
PMID: 16978459 (View on PubMed)

Miller SD, Juricic M, Fajardo N, So J, Shore BJ, Narayanan UG, Mulpuri K. Variability in Postoperative Immobilization and Rehabilitation Following Reconstructive Hip Surgery in Nonambulatory Children With Cerebral Palsy. J Pediatr Orthop. 2021 Aug 1;41(7):e563-e569. doi: 10.1097/BPO.0000000000001850.

Reference Type DERIVED
PMID: 33999564 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

313575

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.